Neurorretinite subaguda unilateral difusa no Brasil: encontro da larva sub-retiniana

Souza, Eduardo Cunha de; Cunha, Sergio Lustosa da

doi:10.5935/0004-2749.19920002

Cited by 9 publications

(4 citation statements)

References 1 publication

(1 reference statement)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…After several trials with oral antihelmintic drugs, such as thiabendazole and diethylcarbamazine, it was found that the tested drugs would only destroy the subretinal worms in some of their patients. Thereby, it was hypothesized that these antihelmintic drugs would depend on an inflamed eye (blood-retinal barrier breakdown), justifying the variable efficacy [20,[49][50][51][52].…”

Section: Oral Treatmentmentioning

confidence: 99%

Diffuse unilateral subacute neuroretinitis: review article

Mazzeo

Motta

Curi

2019

J Ophthal Inflamm Infect

View full text Add to dashboard Cite

Diffuse unilateral subacute neuroretinitis (DUSN) is an ocular infectious disease that can lead to severe visual impairment and blindness. It usually occurs in healthy young individuals and depending on the stage of the disease, it may present as vitritis, multifocal gray-white lesions in the outer retina, and derangement of the retinal pigment epithelium, narrowing of the retinal vessels and optic atrophy. Parasites of different sizes and species have been proposed as the etiologic agent of DUSN, including Ancylostoma caninum, Toxocara canis, and others. Thus, it is hypothesized that different infectious worms may be considered as the likely cause of both an autoimmune and toxic form of nematode retinopathy. Because serologic testing is variable, the definitive diagnosis is made when clinical characteristics of DUSN are found in conjunction with an intraocular worm. Ancillary tests can assist in the differential diagnosis when the nematode cannot be visualized, such as fluorescein and indocyanine green angiography, electrophysiological tests, visual field studies, and more recently, optical coherence tomography angiography. Cases in which the worm can be identified, it is defined as confirmed DUSN, and eyes with the typical clinical features but without identification of the worm should be classified as presumed DUSN. In confirmed DUSN, the classic treatment is directly photocoagulation of the worm; however, it can only be visualized in 30% (to 40%) of cases. Treatment of presumed DUSN cases with high-dose oral albendazole has shown encouraging results. However, perhaps due to the disease's rarity or its underdiagnosis, there are no studies comparing current treatment modalities in both presumed and confirmed DUSN. Due to the possibility of this disease being, in part, autoimmune nematode retinopathy, corticosteroids associated with both albendazole or laser therapy, could be in any way beneficial. Thus, further comparative studies are necessary to elucidate the best treatment for this potentially blinding disease.

show abstract

Section: Oral Treatmentmentioning

confidence: 99%

Diffuse unilateral subacute neuroretinitis: review article

Mazzeo

Motta

Curi

2019

J Ophthal Inflamm Infect

View full text Add to dashboard Cite

show abstract

“…Photocoagulation, the treatment of choice for DUSN, is considered an effective means of destroying the worm, 12,17,41 the search for which can nevertheless be a frustrating task. 42 It seems to offer the best chance for halting worm mobility and for resolution of the active white-yellowish lesions without causing significant intraocular inflammation or toxic damage to the eyes.…”

Section: Laser Treatmentmentioning

confidence: 99%

Diffuse Unilateral Subacute Neuroretinitis—DUSN

Garcia

Sabrosa²,

Gomes³

et al. 2008

International Ophthalmology Clinics

View full text Add to dashboard Cite

“…No Brasil a primeira descrição da doença foi realizada por Oliveira e Oréfice (6) em sete casos de DUSN presumível. A identificação da larva foi feita por Souza e Cunha, em 1992 (7) , e em 1995 Souza e Nakashima (8) retiraram o nematóide subretiniano sendo o mesmo compatível com o estágio terciário da larva do Toxocara canis pelo seu tamanho e morfologia. Recentemente foi relatado um caso de doença bilateral (9) .…”

Section: N T R O D U ç ã Ounclassified